One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
Mechanistic and therapeutic relationships of traumatic brain injury and γ-amino-butyric acid (GABA)☆
Jeffrey M. Witkin a,b,c,�, Hana Shafique d , Rok Cerne a,c,e , Jodi L. Smith a , Ann M. Marini f , Robert H. Lipsky g , Elizabeth Delery
doi : 10.1016/j.pharmthera.2024.108609
Volume 256, April 2024, 108609
Pathological and pharmacological functions of the metabolites of polyunsaturated fatty acids mediated by cyclooxygenases, lipoxygenases, and cytochrome P450s in cancers
Yi-Wen Meng a,b , Jun-Yan Liu
doi : 10.1016/j.pharmthera.2024.108612
Volume 256, April 2024, 108612
Uric acid in health and disease: From physiological functions to pathogenic mechanisms
Shijie Wen, Hiroshi Arakawa, Ikumi Tamai
doi : 10.1016/j.pharmthera.2024.108615
Volume 256, April 2024, 108615
Gene and stem cell therapy for inherited cardiac arrhythmias
Zhong-He Zhang a,b,c , Hector Barajas-Martinez d,e , Hong Jiang a,b,c , Cong-Xin Huang a,b,c , Charles Antzelevitch d,e , Hao Xia a,b,c,�, Dan Hu
doi : 10.1016/j.pharmthera.2024.108596
Volume 256, April 2024, 108596
Nanotechnology and nano-sized tools: Newer approaches to circumvent oncolytic adenovirus limitations
Maryam Mashhadi Abolghasem Shirazi a , Tayebeh Azam Saedi b , Zahra Samadi Moghaddam c , Mahnaz Nemati d , Reza Shiri e , Babak Negahdari f , Nasser Hashemi Goradel
doi : 10.1016/j.pharmthera.2024.108611
Volume 256, April 2024, 108611
Harnessing and delivering microbial metabolites as therapeutics via advanced pharmaceutical approaches
Lindsey M. Williams, Shijie Cao
doi : 10.1016/j.pharmthera.2024.108605
Volume 256, April 2024, 108605
Chemical inhibitors targeting histone methylation readers
Xiaolei Huang, Yichang Chen, Qin Xiao, Xinci Shang, Yanli Liu
doi : 10.1016/j.pharmthera.2024.108614
Volume 256, April 2024, 108614
Immunotherapy in melanoma: Can we predict response to treatment with circulating biomarkers?
Elena Splendiani a , Zein Mersini Besharat a , Alessia Covre b,c , Michele Maio b,c , Anna Maria Di Giacomo b,c , Elisabetta Ferretti
doi : 10.1016/j.pharmthera.2024.108613
Volume 256, April 2024, 108613
The therapeutic potential of targeting the CHD protein family in cancer
Min Zhang a , Kaiyuan Wu e,g,h , Weijie Zhang b,c , Xia Lin a , Qi Cao d , Lili Zhang e,f , Kaifu Chen
doi : 10.1016/j.pharmthera.2024.108610
Volume 256, April 2024, 108610
